Skip to main content

Published locations for FDA expands atogepant approval to include chronic migraine

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands atogepant approval to include chronic migraine

User login

  • Reset your password
  • /content/fda-expands-atogepant-approval-include-chronic-migraine
  • /familypracticenews/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic
  • /fedprac/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic-migraine
  • /internalmedicinenews/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic
  • /neurologyreviews/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic
  • /migraine-icymi/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic
  • /internalmedicine/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic
  • /neurology/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic-migraine
  • /familymedicine/article/262707/headache-migraine/fda-expands-atogepant-approval-include-chronic